drugset / Trial / NCT02079207
Study Immunogenicity and Safety of 13-valent Pneumococcal Conjugate Vaccine
RandomizedParallel-groupQuadruple-blindPrevention
Summary
This study will assess the Immunogenicity and safety of 13-valent Pneumococcal Conjugate Vaccine compared with 23-valent Pneumococcal Polysaccharide Vaccine. All participants should be naïve of Pneumococcal vaccine.
Timeline
- Start
- 2013-12
- Primary completion
- 2014-10
- Completion
- 2015-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | NBP606 | Unknown | 0.5 ml | — |
| Comparator | ProDiax-23 | Vaccine | 0.5 ml | — |